Literature DB >> 23374425

Getting lost in Alzheimer's disease: a break in the mental frame syncing.

Silvia Serino1, Giuseppe Riva.   

Abstract

Despite the clinical significance of topographical disorientation in Alzheimer's disease, it is not clear which cognitive spatial processes are primarily impaired. Here, we argue that a deficit in "mental frame syncing" between egocentric and allocentric spatial representations causes early manifestations of topographical disorientation in AD. Specifically, patients show impairment in translating from an allocentric hippocampal representation to an egocentric parietal one for the purpose of effective spatial orientation and navigation. We suggest that a break in "mental frame syncing", underpinned by damage to the hippocampus and retrosplenial cortex, may be a crucial cognitive marker both for early and differential diagnosis of AD. Identification of these spatial deficits could facilitate the development of early cognitive rehabilitation interventions and the possibility of identifying individuals most at risk for progression to AD during the preclinical stages.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23374425     DOI: 10.1016/j.mehy.2012.12.031

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  16 in total

1.  How different spatial representations interact in virtual environments: the role of mental frame syncing.

Authors:  Silvia Serino; Giuseppe Riva
Journal:  Cogn Process       Date:  2015-02-07

2.  Toward personalized cognitive diagnostics of at-genetic-risk Alzheimer's disease.

Authors:  Gillian Coughlan; Antoine Coutrot; Mizanur Khondoker; Anne-Marie Minihane; Hugo Spiers; Michael Hornberger
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-23       Impact factor: 11.205

3.  Ongoing egocentric spatial processing during learning of non-spatial information results in temporal-parietal activity during retrieval.

Authors:  Alice Gomez; Mélanie Cerles; Stéphane Rousset; Jean-François Le Bas; Monica Baciu
Journal:  Front Psychol       Date:  2013-06-25

Review 4.  Hippocampal volume and navigational ability: The map(ping) is not to scale.

Authors:  Steven M Weisberg; Arne D Ekstrom
Journal:  Neurosci Biobehav Rev       Date:  2021-03-17       Impact factor: 9.052

5.  Detecting early egocentric and allocentric impairments deficits in Alzheimer's disease: an experimental study with virtual reality.

Authors:  Silvia Serino; Francesca Morganti; Fabio Di Stefano; Giuseppe Riva
Journal:  Front Aging Neurosci       Date:  2015-05-20       Impact factor: 5.750

Review 6.  Neural correlates of spatial navigation changes in mild cognitive impairment and Alzheimer's disease.

Authors:  Kamil Vlček; Jan Laczó
Journal:  Front Behav Neurosci       Date:  2014-03-17       Impact factor: 3.558

7.  A Novel Virtual Reality-Based Training Protocol for the Enhancement of the "Mental Frame Syncing" in Individuals with Alzheimer's Disease: A Development-of-Concept Trial.

Authors:  Silvia Serino; Elisa Pedroli; Cosimo Tuena; Gianluca De Leo; Marco Stramba-Badiale; Karine Goulene; Noemi G Mariotti; Giuseppe Riva
Journal:  Front Aging Neurosci       Date:  2017-07-27       Impact factor: 5.750

Review 8.  The Aging Navigational System.

Authors:  Adam W Lester; Scott D Moffat; Jan M Wiener; Carol A Barnes; Thomas Wolbers
Journal:  Neuron       Date:  2017-08-30       Impact factor: 17.173

9.  What is the role of spatial processing in the decline of episodic memory in Alzheimer's disease? The "mental frame syncing" hypothesis.

Authors:  Silvia Serino; Giuseppe Riva
Journal:  Front Aging Neurosci       Date:  2014-03-10       Impact factor: 5.750

10.  Disentangling the Contribution of Spatial Reference Frames to Executive Functioning in Healthy and Pathological Aging: An Experimental Study with Virtual Reality.

Authors:  Silvia Serino; Francesca Morganti; Desirée Colombo; Elisa Pedroli; Pietro Cipresso; Giuseppe Riva
Journal:  Sensors (Basel)       Date:  2018-06-01       Impact factor: 3.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.